Senior Scientist, Biomarkers, Neurodegenerative disorders

Orion Corporation operates in more than 20 countries, where we Orionees, 3400 in total, work in all kinds of positions. Among us there are Research Scientists, Laboratory Technicians, Engineers and IT Specialists as well as people working in Production, just to mention some examples. We offer diverse and responsible jobs to our personnel in a truly multi-disciplinary work environment. We encourage people to develop their competences and offer opportunities to affect the job description and creating their own career path at Orion. We are searching for top talents who are ready to share our passion for the work that we do.
Application period ends: 2018-01-19
Unit: Orion Corporation
Location: Espoo/Turku
Type of employment: Permanent
Description of position: Biomarker and Bioinformatics function is looking for a creative and highly motivated Senior Scientist who is responsible for developing and executing translational biomarker strategies for various CNS-projects.

Responsibilities include the planning and execution of experimental strategies to identify predictive or drug response biomarkers. The work is done in close collaboration with research and development project leaders and pre-clinical and clinical project teams. At the clinical stage you provide scientific leadership for execution of biomarkers assays and research for assigned projects in contract research organisations (CROs) or with academic and clinical collaborators.

This position requires expertise and direct experience in pathogenesis of neurodegenerative disorders. Understanding of genetics and the functional consequences of variants, genes and pathways in disease traits is desirable. As an expert in CNS therapy area you will also contribute to target protein research.

You are able to manage multiple tasks simultaneously, while working in the matrix organization. You follow up the primary scientific literature, keep updated on state of art technologies and emerging biomarker concepts in CNS-drug development.

Building relationships, establishing and managing collaborations with key external stakeholders including academic and clinical collaborators and CROs are part of your duties.

Description of unit: Biomarkers and Bioinformatics function is responsible for developing capabilities to implement translational biomarker research and development strategies to improve predictability of the potential success of new medicines. Responsibilities include identification and implementation of pharmacodynamic, predictive and exploratory biomarkers and analyses in clinical stage studies. We support target discovery and validation with the expertise in therapy area knowledge, genetics and omics technologies.
We offer: We offer exciting opportunities to create and have an impact on future therapies for patients. We also offer attractive career development opportunities and opportunities to develop your own strengths. The culture of Orion R&D is informal and we enjoy working together.

The location is either Espoo or Turku, Finland. If moving to Finland, please check the areas where Finland is considered a leader in the world

http://www.huffingtonpost.com/ira-kalb/finland-is-still-the-worl_b_10774930.html

Join us – together we build well-being and do work that we are proud of!
Requirements: A successful candidate has a Ph.D. in biomedical/biological sciences and experience in investigating disease pathogenesis and biomarkers in neurodegenaration diseases. We value advanced understanding of clinical sample analyses and demonstrated ability to coordinate collaborative projects.

You should have the ability to work proactively and effectively in multidisciplinary teams and possess a highl level of initiative and self-motivation. We also value excellent communication and presentation skills.
Additional information on the position: Are you interested in finding out more? Please contact Elina Serkkola, Head of Biomarkers and Bioinformatics, R&D, tel. +358 50 966 2905

Wed 3rd of January at 2-3 pm (CET+1)
Thu 11th of January at 2-3 pm (CET+1)
Tue 16th of January at 2-3 pm (CET+1)

Approved medical examination which also includes drug testing is required prior to the employment.

Back